249 related articles for article (PubMed ID: 19489432)
1. [Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome].
Morikawa T; Yamashiro Y; Okano K; Kasamatsu M; Sugai H; Kitamura H; Ohba I; Hotta O; Taguma Y; Sakurai J; Kitamoto Y
Rinsho Byori; 2009 Apr; 57(4):319-23. PubMed ID: 19489432
[TBL] [Abstract][Full Text] [Related]
2. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
3. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
4. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
5. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm.
Hosaka A; Miyata T; Aramoto H; Shigematsu H; Nakazawa T; Okamoto H; Shigematsu K; Nagawa H
J Vasc Surg; 2005 Aug; 42(2):200-5. PubMed ID: 16102614
[TBL] [Abstract][Full Text] [Related]
6. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
[TBL] [Abstract][Full Text] [Related]
7. [Activation of hemostasis in patients with chronic cholecystitis].
Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
[TBL] [Abstract][Full Text] [Related]
8. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
Hayashi I; Miyauchi T; Sakamoto K; Sanada J; Nakamura K; Arima T; Otsuji S; Taira A
J Cardiol; 1993; 23(2):177-83. PubMed ID: 8176629
[TBL] [Abstract][Full Text] [Related]
9. [Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation].
Wada H; Takeda Y; Sakakura M; Watanabe R; Nakazaki T; Shiku H; Nishioka J; Nobori T
Rinsho Byori; 2001 Aug; 49(8):813-7. PubMed ID: 11573293
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
11. Relationship between hemostatic factors and the platelet index in patients with ischemic heart disease.
Ihara A; Kawamoto T; Matsumoto K; Shouno S; Morimoto T; Noma Y
Pathophysiol Haemost Thromb; 2006; 35(5):388-91. PubMed ID: 17230041
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.
Kamikura Y; Wada H; Nobori T; Matsumoto T; Shiku H; Ishikura K; Yamada N; Nakano T; Kazahaya Y; Sawai T; Matsuda M
Thromb Res; 2005; 115(1-2):53-7. PubMed ID: 15567453
[TBL] [Abstract][Full Text] [Related]
13. [Molecular marker for detecting hypercoagulable state].
Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
[TBL] [Abstract][Full Text] [Related]
14. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
15. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the role of leukocytes in the activation of intravascular coagulation in septicemia].
Okajima K; Uchiba M; Okabe H; Takatsuki K
Rinsho Byori; 1990 Jul; 38(7):799-805. PubMed ID: 2205743
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
[TBL] [Abstract][Full Text] [Related]
20. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
